OXFORD, United Kingdom, Oct. 29, 2025 (GLOBE NEWSWIRE) — EBC Financial Group (EBC) and the University of Oxford's Department of Economics announce the latest episode of the acclaimed "What Economists Really Do" [...] Read more »
NeOnc Technologies' Subsidiary, NuroMENA, Signs Master Services Agreement with M42’s IROS and Expands Board of Directors
CALABASAS, Calif. and ABU DHABI, United Arab Emirates, Oct. 09, 2025 (GLOBE NEWSWIRE) — NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”), a multi–Phase [...] Read more »
Nilo Therapeutics startet mit einer Serie-A-Finanzierung in Höhe von 101 Mio. USD zur Entwicklung einer neuen Medikamentenklasse, die auf neuronale Schaltkreise bei Immunerkrankungen abzielt, und ernennt Kim Seth zum Chief Executive Officer
NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) — Nilo Therapeutics, ein Biotechnologieunternehmen, das neuronale Schaltkreise nutzt, um die Immunhomöostase bei Krankheiten wiederherzustellen, startete heute mit einer [...] Read more »
Lancement de Nilo Therapeutics avec un financement de série A de 101 millions de dollars en vue de développer une nouvelle classe de médicaments ciblant les circuits neuronaux dans les maladies immunitaires, et nomination de Kim Seth au poste de directeur général
NEW YORK, 09 oct. 2025 (GLOBE NEWSWIRE) — Nilo Therapeutics, une société de biotechnologie qui mise sur les circuits neuronaux pour rétablir l’homéostasie immunitaire chez les patients malades, [...] Read more »
Nilo Therapeutics é lançada com financiamento de US $101 milhões da Série A para promover uma nova classe de medicamentos direcionados a circuitos neurais em doenças imunológicas e nomeia Kim Seth como CEO
NOVA YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) — A Nilo Therapeutics, uma empresa de biotecnologia que utiliza circuitos neurais para restaurar a homeostase imunológica em doenças, foi lançada hoje com um [...] Read more »
Nilo Therapeutics launches with $101 million Series A financing to advance a new class of medicines targeting neural circuits in immune disease and appoints Kim Seth as Chief Executive Officer
NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) — Nilo Therapeutics, a biotechnology company harnessing neural circuits to restore immune homeostasis in disease, launched today with a $101 million Series A financing led by The Column Group [...] Read more »
Axi annonce le départ à la retraite de son directeur commercial, Louis Cooper
SYDNEY, 01 oct. 2025 (GLOBE NEWSWIRE) — Axi, société mondiale de trading en ligne et de fintech de premier plan, annonce aujourd’hui le départ à la retraite de Louis Cooper, directeur commercial. [...] Read more »
Axi anuncia a aposentadoria de seu diretor comercial, Louis Cooper
SIDNEY, Oct. 01, 2025 (GLOBE NEWSWIRE) — Axi, uma das principais empresas globais de negociação on–line e fintech, anuncia hoje a aposentadoria de Louis Cooper, seu diretor comercial. Louis [...] Read more »
Axi Announces Retirement of Chief Commercial Officer Louis Cooper
SYDNEY, Sept. 22, 2025 (GLOBE NEWSWIRE) — Axi, a leading global online trading and fintech company, today announces the retirement of Louis Cooper, Chief Commercial Officer. Louis will formally step down from his executive [...] Read more »
Al Tamimi & Company accueille deux nouveaux associés pour renforcer son offre transfrontalière
DUBAÏ, Émirats arabes unis, 15 sept. 2025 (GLOBE NEWSWIRE) — Al Tamimi & Company, premier cabinet d’avocats pluridisciplinaire du Moyen–Orient, a le plaisir d’annoncer l’arrivée [...] Read more »